Health
EU regulator approves Oxford/AstraZeneca jab but delivery dispute deepens – Financial Times
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Keep abreast of significant corporate, financial and political developments around the world.
Stay informed and spot emerging risks and opportunities with independent global reporting, expert
commentary and analysis you can trust.
Continue Reading
-
Business15 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business14 hours agoHere’s what analysts expect for the BHP share price in the coming year
-
Business17 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM